Utah Medical Products, Inc.
UTMD
$71.10
$0.390.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.11M | 37.53M | 38.52M | 38.63M | 38.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.11M | 37.53M | 38.52M | 38.63M | 38.83M |
| Cost of Revenue | 15.20M | 15.79M | 16.52M | 16.57M | 16.57M |
| Gross Profit | 20.91M | 21.75M | 22.00M | 22.06M | 22.26M |
| SG&A Expenses | 8.25M | 8.78M | 8.57M | 8.27M | 7.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.14M | 25.23M | 25.76M | 25.42M | 24.86M |
| Operating Income | 11.97M | 12.30M | 12.76M | 13.21M | 13.97M |
| Income Before Tax | 12.88M | 13.43M | 14.11M | 14.62M | 15.49M |
| Income Tax Expenses | 2.40M | 2.58M | 2.82M | 3.00M | 2.93M |
| Earnings from Continuing Operations | 10.49 | 10.85 | 11.29 | 11.62 | 12.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.49M | 10.85M | 11.29M | 11.62M | 12.55M |
| EBIT | 11.97M | 12.30M | 12.76M | 13.21M | 13.97M |
| EBITDA | 14.37M | 15.22M | 15.72M | 16.14M | 16.87M |
| EPS Basic | 3.28 | 3.38 | 3.48 | 3.53 | 3.74 |
| Normalized Basic EPS | 2.86 | 2.91 | 2.98 | 3.03 | 3.13 |
| EPS Diluted | 3.28 | 3.38 | 3.48 | 3.53 | 3.74 |
| Normalized Diluted EPS | 2.86 | 2.91 | 2.98 | 3.03 | 3.13 |
| Average Basic Shares Outstanding | 12.77M | 12.84M | 12.96M | 13.15M | 13.42M |
| Average Diluted Shares Outstanding | 12.77M | 12.84M | 12.96M | 13.15M | 13.42M |
| Dividend Per Share | 1.24 | 1.23 | 1.23 | 1.22 | 1.22 |
| Payout Ratio | 37.58% | 36.46% | 35.29% | 34.80% | 32.72% |